[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SK4282001A3 - Imidazo[4,5-c]pyridine-4-one derivative with factor xy inhibiting effect, method for its preparation, its use and pharmaceutical composition comprising same - Google Patents

Imidazo[4,5-c]pyridine-4-one derivative with factor xy inhibiting effect, method for its preparation, its use and pharmaceutical composition comprising same Download PDF

Info

Publication number
SK4282001A3
SK4282001A3 SK428-2001A SK4282001A SK4282001A3 SK 4282001 A3 SK4282001 A3 SK 4282001A3 SK 4282001 A SK4282001 A SK 4282001A SK 4282001 A3 SK4282001 A3 SK 4282001A3
Authority
SK
Slovakia
Prior art keywords
group
pyridin
formula
ylmethyl
isopropyl
Prior art date
Application number
SK428-2001A
Other languages
English (en)
Slovak (sk)
Inventor
Werner Mederski
Horst Juraszyk
Hanns Wurziger
Joachim Gante
Dieter Dorsch
Hans-Peter Buchstaller
Sabine Bernotat-Danielowski
Guido Melzer
Soheila Anzali
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of SK4282001A3 publication Critical patent/SK4282001A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SK428-2001A 1998-10-01 1999-09-09 Imidazo[4,5-c]pyridine-4-one derivative with factor xy inhibiting effect, method for its preparation, its use and pharmaceutical composition comprising same SK4282001A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19845153A DE19845153A1 (de) 1998-10-01 1998-10-01 Imidazo[4,5]-pyridin-4-on-derivate
PCT/EP1999/006655 WO2000020416A1 (de) 1998-10-01 1999-09-09 Imidazo[4,5-c-]-pyridin-4-on-derivate mit faktor xa hemmender wirkung

Publications (1)

Publication Number Publication Date
SK4282001A3 true SK4282001A3 (en) 2002-10-08

Family

ID=7883005

Family Applications (1)

Application Number Title Priority Date Filing Date
SK428-2001A SK4282001A3 (en) 1998-10-01 1999-09-09 Imidazo[4,5-c]pyridine-4-one derivative with factor xy inhibiting effect, method for its preparation, its use and pharmaceutical composition comprising same

Country Status (18)

Country Link
US (1) US6492384B1 (ja)
EP (1) EP1117664A1 (ja)
JP (1) JP2002526542A (ja)
KR (1) KR20010074980A (ja)
CN (1) CN1324358A (ja)
AR (1) AR020688A1 (ja)
AU (1) AU752574B2 (ja)
BR (1) BR9914213A (ja)
CA (1) CA2346033A1 (ja)
DE (1) DE19845153A1 (ja)
HU (1) HUP0104164A3 (ja)
ID (1) ID29466A (ja)
MY (1) MY130736A (ja)
NO (1) NO20011638L (ja)
PL (1) PL346542A1 (ja)
SK (1) SK4282001A3 (ja)
WO (1) WO2000020416A1 (ja)
ZA (1) ZA200103498B (ja)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6858616B2 (en) 1998-12-23 2005-02-22 Bristol-Myers Squibb Pharma Company Nitrogen containing heterobicycles as factor Xa inhibitors
SI1140941T1 (en) 1998-12-23 2005-04-30 Bristol-Myers Squibb Pharma Company Nitrogen containing heterobicycles as factor xa inhibitors
AU2001268712A1 (en) 2000-06-23 2002-01-08 Bristol-Myers Squibb Company 1 - (heteroaryl-phenyl) - condensed pyrazol derivatives as factor Xa inhibitors
AU2002310070A1 (en) 2001-05-22 2002-12-03 Bristol-Myers Squibb Company Bicyclic inhibitors of factor xa
AU2003210958A1 (en) * 2002-02-08 2003-09-02 Glsynthesis Inc. Purine and isosteric antibacterial compounds
GB0215293D0 (en) * 2002-07-03 2002-08-14 Rega Foundation Viral inhibitors
DK1569912T3 (en) 2002-12-03 2015-06-29 Pharmacyclics Inc 2- (2-hydroxybiphenyl-3-yl) -1h-benzoimidazole-5-carboxamidine derivatives as factor VIIa inhibitors.
US7135469B2 (en) * 2003-03-18 2006-11-14 Bristol Myers Squibb, Co. Linear chain substituted monocyclic and bicyclic derivatives as factor Xa inhibitors
JP4970048B2 (ja) * 2003-12-22 2012-07-04 カトリーケ・ウニフェルジテイト・ルーベン・カー・イュー・ルーベン・アール・アンド・ディ イミダゾ［４，５−ｃ］ピリジン化合物および抗ウイルス治療の方法
US7381732B2 (en) * 2004-10-26 2008-06-03 Bristol-Myers Squibb Company Pyrazolobenzamides and derivatives as factor Xa inhibitors
NZ556624A (en) * 2004-12-21 2010-06-25 Gilead Sciences Inc 5-((3-(2,4-trifluoromethyphenyl)isoxazol-5-yl)methyl)-2-(2-fluorophenyl)-5H-imidazo[4,5-c]pyridine and method of antiviral treatment
ATE532518T1 (de) 2005-09-14 2011-11-15 Takeda Pharmaceutical Dipeptidyl-peptidase-hemmer zur behandlung von diabetes
KR101368988B1 (ko) 2005-09-16 2014-02-28 다케다 야쿠힌 고교 가부시키가이샤 디펩티딜 펩티다제 억제제
TW200734338A (en) * 2006-01-16 2007-09-16 Organon Nv 6-Phenyl-1H-imidazo [4,5-c] pyridine-4-carbonitrile derivatives
WO2007112347A1 (en) 2006-03-28 2007-10-04 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
ATE454384T1 (de) * 2006-07-07 2010-01-15 Gilead Sciences Inc Neue pyridazinverbindung und ihre verwendung
TW200838536A (en) 2006-11-29 2008-10-01 Takeda Pharmaceutical Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
UA99466C2 (en) 2007-07-06 2012-08-27 Гилиад Сайенсиз, Инк. Crystalline pyridazine compound
CA2772907C (en) 2009-09-11 2018-01-09 Glsynthesis Inc. Selective antibacterials for clostridium difficile infections

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE574846C (de) * 1933-04-21 Wilhelm Germann Schienenbefestigung unter Verwendung von Schienenfuehrungsleisten
DE602521C (de) * 1934-09-10 Wilhelm Stoeckicht Dipl Ing Umlaufraederwechselgetriebe, insbesondere fuer Kraftfahrzeuge
DE546449C (de) * 1932-03-12 Mueller Paul Verbindung von Belagblechen
DE595151C (de) * 1934-04-04 Buderus Eisenwerk Verfahren und Vorrichtung zum Regeln des Gewichts von in Schleudergussmaschinen herzustellenden Rohren
DE505893C (de) * 1926-08-07 1930-08-26 Medizinische Produkte Ag F Verfahren zur Herstellung von Eiweiss-Halogen-Schwefelverbindungen
DE564960C (de) * 1931-05-13 1932-11-24 Siemens Schuckertwerke Akt Ges Einrichtung zur Anpassung der Drehzahlregelung, insbesondere von Dampfturbinen, an veraenderte Betriebsverhaeltnisse
DE628556C (de) * 1932-12-07 1936-04-08 Wolf Johannes Mueller Dr Verfahren zur Herstellung von insbesondere hochkonzentrierten Wasserglasloesungen
DE702013C (de) * 1933-07-17 1941-01-29 Union Oil Co Verfahren zur Abscheidung von Paraffin aus paraffinhaltigen OElen
DE4110019C2 (de) 1991-03-27 2000-04-13 Merck Patent Gmbh Imidazopyridine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
US5798364A (en) * 1992-03-26 1998-08-25 Merck Patent Gesellschaft Mit Beschrankter Haftung Imidazopyridines
DE4140519A1 (de) 1991-12-09 1993-06-17 Merck Patent Gmbh Benzofurane
DE4211474A1 (de) 1992-04-06 1993-10-07 Merck Patent Gmbh Imidazopyridine
DE4305602A1 (de) * 1992-06-17 1993-12-23 Merck Patent Gmbh Imidazopyridine
DE4236026A1 (de) 1992-10-24 1994-04-28 Merck Patent Gmbh Imidazopyridine
DE4242459A1 (de) * 1992-12-16 1994-06-23 Merck Patent Gmbh Imidazopyridine
DE4318813A1 (de) * 1993-06-07 1994-12-08 Merck Patent Gmbh Imidazopyridine
DE4432860A1 (de) * 1994-09-15 1996-03-21 Merck Patent Gmbh Imidazopyridine
EP0960102A1 (en) 1996-07-08 1999-12-01 Du Pont Pharmaceuticals Company AMIDINOINDOLES, AMIDINOAZOLES, AND ANALOGS THEREOF AS INHIBITORS OF FACTOR Xa AND OF THROMBIN

Also Published As

Publication number Publication date
AR020688A1 (es) 2002-05-22
HUP0104164A2 (hu) 2002-04-29
NO20011638D0 (no) 2001-03-30
CN1324358A (zh) 2001-11-28
MY130736A (en) 2007-07-31
KR20010074980A (ko) 2001-08-09
HUP0104164A3 (en) 2002-08-28
BR9914213A (pt) 2001-06-26
ZA200103498B (en) 2002-08-13
EP1117664A1 (de) 2001-07-25
AU752574B2 (en) 2002-09-26
DE19845153A1 (de) 2000-04-06
JP2002526542A (ja) 2002-08-20
US6492384B1 (en) 2002-12-10
ID29466A (id) 2001-08-30
NO20011638L (no) 2001-03-30
PL346542A1 (en) 2002-02-11
WO2000020416A1 (de) 2000-04-13
AU5861899A (en) 2000-04-26
CA2346033A1 (en) 2000-04-13

Similar Documents

Publication Publication Date Title
SK4282001A3 (en) Imidazo[4,5-c]pyridine-4-one derivative with factor xy inhibiting effect, method for its preparation, its use and pharmaceutical composition comprising same
CZ20012407A3 (cs) Derivát imidazol [4,5-c]pyridin-4-onu, způsob jeho přípravy, jeho pouľití a farmaceutický prostředek, který ho obsahuje
AU2006286535A1 (en) Novel cycloalkane carboxamides as factor Xa inhibitors
US20030018023A1 (en) 5-6 or 5-7 Heterobicycles as Factor Xa inhibitors
KR20060023154A (ko) 혈전증 치료용 응고 인자 ｘａ 및 ｖｉｉａ의 저해제로서의피롤리딘-１,２-디카르복실산-１-[(４-에티닐-페닐)-아미드]-２-[(페닐)-아미드] 유도체
MXPA05010445A (es) Derivados de azaprolina.
AU2010286933A1 (en) Morpholinone compounds as factor IXa inhibitors
US6750225B2 (en) 1,4,5,6-tetrahydropyrazolo-[3,4,-c]-pyridin-7-ones useful as factor Xa inhibitors
JP4732757B2 (ja) カルボキサミド
AU2916500A (en) Pyrazole-3-on-derivative as factor xa inhibitors
JP4699985B2 (ja) カルボキサミド誘導体及びその第Ｘａ因子の阻害剤としての使用
JP4567439B2 (ja) カルボン酸アミド
SK2652001A3 (en) 2-oxo-i(2h)-quinoline derivatives
MXPA01006942A (en) Imidazo[4,5-c]-pyridine-4-on-derivatives
CZ2001680A3 (cs) Derivát 2-oxo-2H-chinoIinu, způsob jeho přípravy, jeho použití a farmaceutický prostředek, který ho obsahuje
JP2005530754A (ja) 血栓塞栓症に有効なセミカルバジド誘導体
AU2003270223A1 (en) Heterocyclic amides and their use in treating thromboembolic diseases and tumors
CA2581737A1 (en) Proline derivatives
KR20040095256A (ko) 세미카르바자이드 유도체 및 항혈전제로서의 이의 용도